Literature DB >> 24559777

Enhancing nurse contributions to SWOG clinical trials.

Lisa K Hansen, Carol M Moinpour, Rose B Ermete.   

Abstract

OBJECTIVES: To review nursing research contributions and future opportunities for nurses in cooperative oncology group research in SWOG (formerly Southwest Oncology Group). DATA SOURCES: Peer-reviewed journal articles, grant submissions, professional manuals, research policy reports, and meeting minutes.
CONCLUSION: Nurses and nurse researchers have had active roles in SWOG research involving quality of life, symptom management, recruitment and adherence, and data quality. There are opportunities for nurses to make greater contributions to cooperative group research, particularly in cancer survivorship, health outcomes, and quality of life. IMPLICATIONS FOR NURSING PRACTICE: Nursing science and evidence-based practice will be enhanced by conducting nursing research in the multi-site cooperative group setting.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cooperative group; SWOG; nursing research; quality of life

Mesh:

Year:  2013        PMID: 24559777      PMCID: PMC3961058          DOI: 10.1016/j.soncn.2013.12.005

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  28 in total

Review 1.  Behavioral science research in the cooperative group setting: the Southwest Oncology Group experience.

Authors:  C C Gotay; C M Moinpour; S Moody-Thomas; E R Gritz; K S Albain; E DeAntoni; L Hansen; P A Ganz
Journal:  J Natl Cancer Inst       Date:  2000-09-06       Impact factor: 13.506

2.  A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).

Authors:  Sara H Javid; Joseph M Unger; Julie R Gralow; Carol M Moinpour; Antoinette J Wozniak; J Wendall Goodwin; Primo N Lara; Pamela A Williams; Laura F Hutchins; Carolyn C Gotay; Kathy S Albain
Journal:  Oncologist       Date:  2012-06-20

3.  Health-related quality-of-life findings for the prostate cancer prevention trial.

Authors:  Carol M Moinpour; Amy K Darke; Gary W Donaldson; Duane Cespedes; Christine R Johnson; Patricia A Ganz; Donald L Patrick; John E Ware; Sally A Shumaker; Frank L Meyskens; Ian M Thompson
Journal:  J Natl Cancer Inst       Date:  2012-09-12       Impact factor: 13.506

4.  Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases.

Authors:  C M Moinpour; B Lyons; S P Schmidt; K Chansky; R A Patchell
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

5.  Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial.

Authors:  C M Moinpour; J Sawyers Triplett; B McKnight; L C Lovato; C Upchurch; C G Leichman; F M Muggia; L Tanaka; W A James; M Lennard; F L Meyskens
Journal:  Psychooncology       Date:  2000 Jul-Aug       Impact factor: 3.894

6.  Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.

Authors:  Carol M Moinpour; Nancy L Vaught; Bryan Goldman; Mary W Redman; Philip A Philip; Barbara Millwood; Scott M Lippman; Thomas E Seay; Patrick J Flynn; Eileen M O'Reilly; Kendrith M Rowland; Ralph P Wong; Jacqueline Benedetti; Charles D Blanke
Journal:  J Clin Oncol       Date:  2010-07-06       Impact factor: 44.544

7.  Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.

Authors:  Carol M Moinpour; Katherine A Hayden; Joseph M Unger; Ian M Thompson; Mary W Redman; Edith D Canby-Hagino; Betsy A Higgins; Jerry W Sullivan; Dianne Lemmon; Sheila Breslin; E David Crawford
Journal:  J Clin Oncol       Date:  2008-01-01       Impact factor: 44.544

8.  Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

Authors:  Carol M Moinpour; Amy K Darke; Gary W Donaldson; Ian M Thompson; Connie Langley; Donna Pauler Ankerst; Donald L Patrick; John E Ware; Patricia A Ganz; Sally A Shumaker; Scott M Lippman; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2007-06-27       Impact factor: 13.506

9.  Intermittent versus continuous androgen deprivation in prostate cancer.

Authors:  Maha Hussain; Catherine M Tangen; Donna L Berry; Celestia S Higano; E David Crawford; Glenn Liu; George Wilding; Stephen Prescott; Subramanian Kanaga Sundaram; Eric Jay Small; Nancy Ann Dawson; Bryan J Donnelly; Peter M Venner; Ulka N Vaishampayan; Paul F Schellhammer; David I Quinn; Derek Raghavan; Benjamin Ely; Carol M Moinpour; Nicholas J Vogelzang; Ian M Thompson
Journal:  N Engl J Med       Date:  2013-04-04       Impact factor: 91.245

10.  Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.

Authors:  Dawn L Hershman; Joseph M Unger; Katherine D Crew; Lori M Minasian; Danielle Awad; Carol M Moinpour; Lisa Hansen; Danika L Lew; Heather Greenlee; Louis Fehrenbacher; James L Wade; Siu-Fun Wong; Gabriel N Hortobagyi; Frank L Meyskens; Kathy S Albain
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544

View more
  1 in total

Review 1.  The importance of patient-reported outcomes in clinical trials and strategies for future optimization.

Authors:  Rebecca Mercieca-Bebber; Madeleine T King; Melanie J Calvert; Martin R Stockler; Michael Friedlander
Journal:  Patient Relat Outcome Meas       Date:  2018-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.